• Profile
Close

Increased B Cell activity with consumption of activated monocytes in severe COVID‐19 patients

European Journal of Immunology Apr 05, 2021

Kos I, Balensiefer B, Lesan V, et al. - As lacunae remain concerning the pathogenesis of auto‐immune complications triggered by SARS‐CoV2, researchers herein analyzed cellular immune status, cell ratios and monocyte populations of patients with COVID‐19 treated on the intensive care unit (ICU) (cohort 1, N = 23) and normal care unit (NCU) (cohort 2, n = 10) compared with control groups: patients treated on ICU for non‐infectious reasons (cohort 3, n = 30) and patients treated on NCU for infections other than COVID‐19 (cohort 4, n = 21). Patients in cohort 1 significantly differed from the other cohorts, as they had reduced frequencies of lymphocytes, reduced CD8+T‐cell count, reduced percentage of activated and intermediate monocytes and an elevated B/T8 cell ratio. Levels of IgG1 and IgG3 were significantly higher in cohort 1, whereas levels of IgG3 were higher in cohort 3 when compared with controls. Patients with severe COVID‐19 mainly showed an elevated B/T8 cell ratio and a reduced rate of activated monocytes among many immune changes. Both parameters were noted to be linked with with death in cohort 1.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay